002550 千紅製藥
按盤價 
6.770 -0.150 (-2.168%)
6.770 -0.150 (-2.168%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 3.026 | 15.091 | 14.320 | 7.415 | 14.130 |
| 總資產報酬率 ROA (%) | 2.692 | 13.476 | 12.723 | 6.528 | 12.171 |
| 投入資產回報率 ROIC (%) | 3.010 | 14.951 | 14.028 | 7.138 | 13.454 | 邊際利潤分析 |
| 銷售毛利率 (%) | 61.080 | 58.356 | 54.852 | 43.265 | 38.591 |
| 營業利潤率 (%) | 28.689 | 28.998 | 25.972 | 11.264 | 15.628 |
| 息稅前利潤/營業總收入 (%) | 30.948 | 28.957 | 25.137 | 10.866 | 12.422 |
| 淨利潤/營業總收入 (%) | 23.598 | 23.755 | 21.830 | 9.848 | 13.888 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 90.425 | 69.097 | 74.144 | 72.829 | 86.680 |
| 價值變動淨收益/利潤總額(%) | 3.923 | 4.030 | 3.509 | 4.312 | -1.273 |
| 營業外收支淨額/利潤總額(%) | 0.067 | -1.210 | -0.139 | -0.409 | 0.090 | 償債能力分析 |
| 流動比率 (X) | 7.296 | 8.468 | 7.582 | 7.900 | 6.065 |
| 速動比率 (X) | 5.843 | 6.817 | 5.671 | 4.975 | 4.136 |
| 資產負債率 (%) | 11.752 | 10.425 | 11.089 | 10.563 | 13.276 |
| 帶息債務/全部投入資本 (%) | -3.059 | -2.908 | -2.225 | -0.654 | 1.024 |
| 股東權益/帶息債務 (%) | -3,253.565 | -3,419.328 | -4,435.120 | -14,863.128 | 9,308.957 |
| 股東權益/負債合計 (%) | 751.492 | 859.719 | 802.064 | 840.232 | 657.760 |
| 利息保障倍數 (X) | 13.820 | 94.604 | -31.468 | -30.840 | -3.857 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 59.462 | 58.621 | 56.541 | 78.390 | 75.078 |
| 存貨周轉天數 (天) | 250.700 | 219.862 | 268.752 | 199.089 | 119.244 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 18/05/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
